James Intrater

Insider Reports History

Reporting-owner location: Chicago, IL
Latest reporting-owner signature: /s/ Elisa Luqman as attorney-in-fact for James Intrater
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for James Intrater

Form 4 holding Director

Cardio Diagnostics Holdings, Inc.

Security class: Stock Options (Right to Buy)
Shares / value: 10,464
Estimated value: $19,671
Report date: 31 Mar 2026
Price: $2.71
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by James Intrater

4 CDIO

Cardio Diagnostics Holdings, Inc.

Report period: 31 Mar 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Apr 2026, 14:08
Role: Director
Next action: Open filing details

4 CDIO

Cardio Diagnostics Holdings, Inc.

Report period: 31 Dec 2025
Transactions: 1
Transaction value: +$6,249
Accepted by SEC: 06 Jan 2026, 14:13
Role: Director
Next action: Open filing details

4 CDIO

Cardio Diagnostics Holdings, Inc.

Report period: 30 Sep 2025
Transactions: 1
Transaction value: +$6,252
Accepted by SEC: 03 Oct 2025, 16:17
Role: Director
Next action: Open filing details

4 CDIO

Cardio Diagnostics Holdings, Inc.

Report period: 30 Jun 2025
Transactions: 1
Transaction value: +$6,250
Accepted by SEC: 02 Jul 2025, 19:05
Role: Director
Next action: Open filing details

4 CDIO

Cardio Diagnostics Holdings, Inc.

Report period: 31 Mar 2025
Transactions: 1
Transaction value: +$6,250
Accepted by SEC: 01 Apr 2025, 12:40
Role: Director
Next action: Open filing details

4 CDIO

Cardio Diagnostics Holdings, Inc.

Report period: 31 Dec 2024
Transactions: 1
Transaction value: +$4,180
Accepted by SEC: 15 Jan 2025, 16:59
Role: Director
Next action: Open filing details

4 CDIO

Cardio Diagnostics Holdings, Inc.

Report period: 30 Sep 2024
Transactions: 1
Transaction value: +$4,111
Accepted by SEC: 10 Oct 2024, 16:47
Role: Director
Next action: Open filing details

4 CDIO

Cardio Diagnostics Holdings, Inc.

Report period: 30 Jun 2024
Transactions: 1
Transaction value: +$4,166
Accepted by SEC: 02 Jul 2024, 17:48
Role: Director
Next action: Open filing details

4 CDIO

Cardio Diagnostics Holdings, Inc.

Report period: 31 Mar 2024
Transactions: 2
Transaction value: +$25,000
Accepted by SEC: 08 Apr 2024, 15:07
Role: Director
Next action: Open filing details

4 CDIO

Cardio Diagnostics Holdings, Inc.

Report period: 23 Jan 2024
Transactions: 1
Transaction value: +$50,000
Accepted by SEC: 21 Feb 2024, 18:09
Role: Director
Next action: Open filing details

4 CDIO

Cardio Diagnostics Holdings, Inc.

Report period: 31 Dec 2023
Transactions: 2
Transaction value: -$0.2
Accepted by SEC: 02 Jan 2024, 17:58
Role: Director
Next action: Open filing details

4/A CDIO

Cardio Diagnostics Holdings, Inc.

Report period: 30 Sep 2023
Transactions: 2
Transaction value: +$0.1
Accepted by SEC: 04 Oct 2023, 11:34
Role: Director
Next action: Open filing details

4 CDIO

Cardio Diagnostics Holdings, Inc.

Report period: 30 Jun 2023
Transactions: 2
Transaction value: +$50,000
Accepted by SEC: 05 Jul 2023, 13:19
Role: Director
Next action: Open filing details

4 CDIO

Cardio Diagnostics Holdings, Inc.

Report period: 19 Jun 2023
Transactions: 1
Transaction value: +$50,000
Accepted by SEC: 21 Jun 2023, 17:03
Role: Director
Next action: Open filing details

3 CDIO

Cardio Diagnostics Holdings, Inc.

Report period: 25 Oct 2022
Transactions: 0
Transaction value: $0
Accepted by SEC: 03 Nov 2022, 11:11
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .